Moleculin Biotech, Inc.
MBRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $8 | $8 | $4 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $2 | $1 |
| Total Curr. Assets | $8 | $9 | $9 | $5 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $11 | $11 | $11 | $11 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $12 | $13 | $12 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $20 | $22 | $21 | $17 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $3 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $4 | $4 | $3 |
| Total Curr. Liab. | $6 | $8 | $7 | $5 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $41 | $21 | $14 | $5 |
| Total NC Liab. | $42 | $21 | $14 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $47 | $29 | $21 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$222 | -$167 | -$160 | -$153 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $195 | $160 | $160 | $159 |
| Total Equity | -$27 | -$7 | $0 | $6 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $20 | $22 | $21 | $17 |
| Net Debt | -$6 | -$7 | -$7 | -$4 |